Offering broader access to sustainable and scalable pharma-grade saponin adjuvants
/PRNewswire/ -- SPI Pharma, Inc. (SPI) and Q-Vant Biosciences, Inc. (Q-Vant) have partnered to leverage Q-Vant's leadership in unique, sustainable saponin...
Stay updated with breaking news from Doug Klaiber. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- SPI Pharma, Inc. (SPI) and Q-Vant Biosciences, Inc. (Q-Vant) have partnered to leverage Q-Vant's leadership in unique, sustainable saponin...
BOSTON, MA (ots) - --News Direct--Q-VANT Biosciences, the first company to achieve a 100% sustainable way to meet the growing global vaccine market demand for Quillaja saponin-based adjuvants, today announced that it has signed an agreement with In vitro Plant-tech AB, a Swedish plant cell cultivation company whose technology platform and manufactu...
Enhances Q-VANT’s 100% sustainable supply for next-generation saponin adjuvants BOSTON, MA | March 08, 2022 Q-VANT Biosciences, the first company to achieve a 100% sustainable way . Q-VANT and In vitro Plant-tech Sign Agreement for the Development and Supply of Quillaja saponaria Plant Cell Culture Biomass | EFE Comunica | Agencia EFE